BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29762257)

  • 41. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
    Moos SI; Stoker J; Nagan G; de Weijert RS; van Vemde DN; Bipat S
    Eur Radiol; 2014 Jun; 24(6):1266-75. PubMed ID: 24663822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
    Habib M; Hillis A; Hammad A
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):55-61. PubMed ID: 26787567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.
    Ma G; Li M; Teng W; He Z; Zhai X; Xia Z
    Medicine (Baltimore); 2022 Jan; 101(4):e28683. PubMed ID: 35089218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term safety of withholding standard prophylaxis in patients with moderate chronic kidney disease.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen GV; Wildberger JE
    Eur Radiol; 2023 Jan; 33(1):627-632. PubMed ID: 35763097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
    Weisbord SD; Hartwig KC; Sonel AF; Fine MJ; Palevsky P
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):879-85. PubMed ID: 18412255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial.
    Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Kazemisaeid A; Soleimani A; Pourhosseini HR; Alidoosti M; Hajizeinali AM; Hoseini K; Nematipour E
    J Nephrol; 2010; 23(2):216-23. PubMed ID: 20175053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A retrospective evaluation of contrast-induced kidney injury in dogs (2006-2012).
    Goic JB; Koenigshof AM; McGuire LD; Klinger AC; Beal MW
    J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):713-9. PubMed ID: 27557489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
    McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.
    Fukushima Y; Miyazawa H; Nakamura J; Taketomi-Takahashi A; Suto T; Tsushima Y
    Jpn J Radiol; 2017 Aug; 35(8):427-431. PubMed ID: 28528465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.
    Liu Y; Chen JY; Tan N; Zhou YL; Yu DQ; Chen ZJ; He YT; Liu YH; Luo JF; Huang WH; Li G; He PC; Yang JQ; Xie NJ; Liu XQ; Yang DH; Huang SJ; Piao-Ye ; Li HL; Ran P; Duan CY; Chen PY
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26041500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.